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Cellular protein delivery is an emerging technique, by which exogenous recombinant proteins are delivered into mammalian cells across the
membrane. We have developed an E. coli expression vector suited for protein cellular delivery experiments. The plasmid is designed to generate a
C-terminal fusion with the 12 amino acid HIV-Tat peptide as a protein transduction domain (PTD), whereas the protein N-terminus is fused to an
17-residue peptide lanthanide-binding tag (LBT). LBT is used for both purification by affinity chromatography and fluorescent detectionwith Tb3+ as
a coordinating metal. We have employed the TA-cloning site between the two tags, LBT and PTD, according to the PRESAT-vector
methodology [N. Goda, T. Tenno, H. Takasu, H. Hiroaki, M. Shirakawa, The PRESAT-vector: asymmetric T-vector for high-throughput
screening of soluble protein domains for structural proteomics, Protein Sci. 13 (2004) 652–658], which facilitates unidirectional cloning of any
PCR-amplified DNA fragments corresponding to the protein of interest. A simple three-step protocol consisting of affinity purification of LBT/
PTD dual-tagged proteins has also been developed, in which the proteins are purified by heparin-, then immobilized Ni2+-, and then heparin-
affinity chromatography, in this order. The purified protein is ready for protein delivery experiment, and the delivered protein is visible by
fluorescent microscopy. Our LBT/PTD dual-tagged PRESAT-vector provides a powerful research tool for exploring cellular functions of proteins
in the post-genomic era.
© 2006 Elsevier B.V. All rights reserved.Keywords: HIV tat protein; Unidirectional PCR cloning; Fluorescence microscopy in living cells; Lanthanide binding tag; Terbium(III) fluorescence1. Introduction
Cellular delivery of exogenous proteins across the plasma
membrane of cells is a key technology for protein therapy [1].Abbreviations: GST, glutathione-S-transferase; HTS, high throughput
screening; IPTG, isopropyl-β-D-thiogalactopyranoside; LB, Luria Broth
media; DMEM, Dulbecco's modified Eagle's medium; OD, optical density;
SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophoresis; PCR,
polymerase chain reaction; PRESAT-vector, Potential Restriction Enzyme
Selectable Asymmetric T-vector; LBT, lanthanide binding tag; PTD, protein
transduction domain; Ub, ubiquitin; NTR, neurotrophin receptor; DD, death
domain
⁎ Corresponding author. Tel.: +81 45 508 7214; fax: +81 45 508 7361.
E-mail address: hiroakih@tsurumi.yokohama-cu.ac.jp (H. Hiroaki).
0167-4889/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.11.016Unlike small molecules or peptides, proteins can merely
permeate into mammalian cells from outside the membrane.
Several arginine-rich peptide sequences, known as protein
transduction domains (PTD), can serve as carriers for protein
delivery, including HIV-Tat [2,3], the DNA binding helix of
Drosophila antennapedia [4] and synthetic arginine oligopep-
tide [5]. One of the most potent PTD is HIV-Tat(49–57),
RKKRRQRRR, which is widely used for cell biology with an
aim to developing clinical applications. HIV-Tat(49–57) is
known to deliver cargo proteins of having various molecular
weights up to 120 kDa [6], whereas HIV-Tat can be fused in-
frame at either the N- or C-terminus of the cargo proteins [7].
One major experimental drawback of the technique is the
tedious vector construction and purification of the fusion
protein.
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delivery experiments. Fluorescent detection of proteins using
fluorescence-labeled antibodies, chemically attached dyes, or
green fluorescent protein is necessary to monitor the progress of
protein uptake. Recently, the lanthanide binding tag (LBT), a
designed 17 amino acid sequence that binds to various lanthanides
with Kds ranging 57 nM to 4 μMhas been developed [8,9].When
Tb3+ is used as a chelating ion, the LBT–lanthanide complex
gives rise to a fluorescent signal (λex=277 nm, λem=540 nm)
allowing detection of LBT-fusion proteins.
In this study, we report an application of LBT/PTD dual-
tagged fusion proteins which are bacterially expressed and
delivered into mammalian cells. In addition, we have
developed a simple three-step purification protocol for the
LBT/PTD dual-tagged proteins using heparin affinity chroma-
tography followed by immobilized Ni2+-affinity chromatogra-
phy. The cloning site of the LBT/PTD dual-tagged expression
vector is suited for unidirectional PCR cloning, based on our
PRESAT-vector (Potential Restriction Enzyme Selectable
Asymmetric T-vector) methodology [10]. This technique
enables us to incorporate PCR-amplified cDNA fragments of
proteins with a minimal effort with a very low background. The
ability of the LBT/PTD dual-tag fusion system to express,
purify, deliver and visualize recombinant proteins was demon-
strated in this study using glutathione S-transferase (GST) as a
model cargo protein.
2. Materials and methods
2.1. Materials
The restriction enzymes AhdI, KpnI, NdeI, XhoI and BamHI (New England
Biolabs) were used. T4 DNA ligase, a Wizard plus SV Minipreps DNA
purification and a Wizard SV Gel and PCR Clean-up systems (Promega) were
used for ligation and DNA purification. Oligonucleotide primers were obtained
from Hokkaido System Science (Sapporo, Japan). The pGEX-4T3 was
purchased from Amersham Bioscience. For PCR cloning, rTaq (TAKARA)
was used, while a plasmid containing ubiquitin genes with mutations was used
as a template [11].
2.2. Vector construction
The plasmid encoding the N-terminal LBT tag (MGYIDTNNDGWYEG-
DELLA) followed by the PRESAT-linker, which harbors two tandem
asymmetric AhdI sites (pET–LBT–PRESAT) was made from pET-TRX-
PRESAT [11] by replacing the region containing TRX-His6 with LBT by
PCR-mutation. A synthetic oligonucleotide duplex corresponding to the Tat
peptide (YGRKKRRQRRR-stop) was inserted between the BamHI and XhoI
sites of pGEX-4T3 (Amersham Bioscience), C-terminal to GST, resulting in
pGEX–GST–PTD, in which an additional NdeI site was engineered at the 5′
region preceding GST. Next, an NdeI–NdeI fragment containing the LBT region
was inserted 5′ to the GST in pGEX–GST–PTD, resulting in pGEX–LBT–
GST–PTD, and a clone with the desired insert orientation was confirmed by
nucleotide sequencing. Next, the first of the two NdeI sites and an endogenous
AhdI site within the AmpR gene were disrupted by site-directed mutagenesis
using GeneEditor (Promega) according to manufacturer's instructions. Finally,
the fragment containing the PRESAT-linker taken from pET–LBT–PRESATwas
used to replace the region encodingGSTof pGEX–LBT–GST–PTD, resulting in
pGEX–LBT–PRESAT–PTD. Note that pGEX–LBT–PRESAT–PTD becomes
competent for unidirectional TA-cloning after linearization by AhdI (typically
2 μg plasmids with 15 U AhdI, 37 °C for 60 min) according to the reference [11].
For a demonstration, we have cloned two genes, mouse ubiquitin mutant (L8A/I44A/V70A/D77, designated UbM here after) and mouse neurotrophin receptor
p75 death domain (residues 336–420, designated NTRDD). Detailed conditions
are described in the legend of Supplementary Fig. 2.
2.3. Protein techniques
E. coli BL21(DE3) transformed by pGEX-based vectors (pGEX–LBT–
GST–PTD, pGEX–GST–PTD and pGEX–LBT–PRESAT–PTD carrying
proteins, pGEX–LBT–UbM–PTD and pGEX–LBT–NTRDD–PTD) were
grown in LB-Glucose medium at 30 °C. Expression of the recombinant
proteins was induced with IPTG (1 mM) when the cell density reached an OD
(600) of 0.4. Cells were harvested 24 h at 20 °C after induction, and the cell
extracts were analyzed by 15% SDS-PAGE. The cells were broken by
sonication in a buffer containing 0.3 M NaCl and 50 mM Na-phosphate buffer
(pH 7.4), and centrifuged to remove the pellet. LBT/PTD dual-tagged proteins
were purified by sequential affinity chromatography: heparin–Sepharose Fast
Flow, Ni2+-charged chelating-Sepharose Fast Flow and again heparin–
Sepharose Fast Flow (Amersham Biosciences), in this order. The crude extract
was applied to the first heparin Sepharose column, washed with approximately
10 bed-volumes of 0.3 M NaCl, 50 mM Na-phosphate buffer (pH 7.4), and
then the protein was eluted by the same buffer with 1.0 M NaCl. The eluent
was applied directly to the second Ni2+-chelating column, washed with
approximately 10 volumes of the same wash buffer, and the protein was eluted
with 5 volumes of 0.1 M imidazole, 50 mM Na-phosphate (pH 7.4). Finally,
the eluent was applied directly to the heparin column again, which was washed
and eluted as before. Alternatively, the crude extract containing LBT–GST–
PTD was applied to a glutathione–Sepharose Fast Flow column (Amersham
Bioscience), and the protein was purified based on affinity to glutathione
according to the manufacturer's instructions. Tb3+-chelated LBT–GST–PTD
was prepared by adding aliquots of Tb3+ stock solution (10 mM TbCl3 in H2O)
to the 100 μM protein solution at a final Tb3+ concentration of 50 μM.
2.4. Cell lines
HeLa and NIH3T3 cells were used in all experiments. Cells were cultured
in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%
(v/v) fetal bovine serum, 100 units/mL penicillin, and 100 units/mL
streptomycin, and were incubated in humidified CO2 containing (5%) air at
37 °C.
2.5. Cellular protein delivery experiment
HeLa and NIH3T3 cells were grown in 6-well ×35 mm plates (SUMILON,
Japan) to approximately 30% confluence, and the medium was discarded. Fresh
DMEM containing the recombinant proteins at a final concentration of 1–2 μM
was then added. After 5 h of incubation, cells were washed twice with PBS and
released from the dish with PBS containing trypsin (0.01%). The cell lysates
were subjected to Western blotting analysis and the amount of protein delivered
was quantified. Approximately 106 cells were collected and pelleted. The cells
were washed with PBS three times, broken by sonication in 50 μL buffer
containing 0.1 M Tris–HCl (pH 7.5), 1% SDS and 1% 2-mercaptoethanol. The
lysates were electrophoresed on 15% SDS-PAGE, blotted onto a PVDF
membrane, then the proteins of interest were detected by 1/20,000 diluted anti-
GST antibody (Code 04435-84, Nacalai Tesque Co., Kyoto, Japan) followed by
an HRP-conjugated anti-mouse IgG secondary antibody, and visualized using an
ECL-Plus kit (Amersham Bioscience).
2.6. Fluorescent microscopy
Cells were grown either on chamber slides (Matsunami-glass Co, Osaka) in
normal 35 mm dishes or on glass-bottom 35 mm dishes (Matsunami-glass Co,
Osaka) to about 30% confluence. Protein delivery experiments were performed
as described above, with either the Tb3+-free or Tb3+-chelated recombinant
proteins at a concentration of 2 μM. After 5 h of incubation, cells were washed
twice with PBS and fixed with methanol for 20 min −20 °C. For immunological
staining, fixed cells were subsequently washed twice with 0.1% Tween 20 in
TBS for 10 min and incubated with antibodies in TBS supplemented with 0.1%
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incubated with the secondary antibody (Cy3™-conjugated anti mouse IgG
antibody, C2181, Sigma, Co) and 0.1% Tween 20 in TBS for 60 min, and then
mounted in Prolong Antifade mounting medium (Molecular Probes, Inc). DAPI
(final 10 ng/ml) and Tb3+ (final 1 μM) was added 10 min before fixation for
post-delivery staining of Tb3+-free LBT–GST–PTD, while only DAPI was used
for staining of Tb3+-chelated LBT–GST–PTD. Alternatively, living cells
growing on the glass-bottom dishes were observed without fixation. Images
were obtained by fluorescence microscopy using an IX71 microscope equipped
with a DP-70 color CCD camera system (Olympus, Tokyo). A UV-excited/wide
range VIS-emitted mirror unit (U-MWU2, Olympus, Tokyo) was used to
observe Tb3+ fluorescence.Fig. 1. Construction of the LBT/PTD-dual-tagged PRESAT-vector. (a) Vector map o
corresponding to LBTand PTD are underlined. (b) Schematic representation of the un
The gene is cloned and further subjected to ORF selection by KpnI treatment. The rea
only the ligated plasmid with the insert in the reverse orientation will have the Kpn3. Results
3.1. Design of LBT/PTD dual-tagged PRESAT vector
Fig. 1 illustrates a map of the LBT/PTD dual-tagged
PRESAT-vector with the scheme for unidirectional TA-cloning
of PCR-amplified DNA fragments. The genes were cloned
between the two 3′ T-overhanging sites which were created by
AhdI digestion. The front (or forward) and rear (or reverse)
primers were designed in frame to both the LBT and TAT tagsf pGEX–LBT–PRESAT–PTD after AhdI digestion. The amino acid sequences
idirectional TA-cloning of the PCR fragment into pGEX–LBT–PRESAT–PTD.
r PCR primer is designed with an addition of 5′-ACC at the 5′ terminus, so that
I site at the TA-cloning position.
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attached to the 5′ end of the rear (or reverse) primer, in order to
enable subsequent KpnI treatment to select the desired ORF
orientation (Fig. 1, bottom). If the PCR product is ligated to the
vector in the opposite direction, the product will be digested by
KpnI and will give no transformed colonies. All other protocols
and conditions were according to the original PRESAT-vector
methodology [10].
3.2. Affinity purification of LBT/PTD dual-tagged proteins
We have focused on the ability of the Tat-PTD peptide to
bind heparin [12,13], as well as the affinity of LBT for the
immobilized Ni2+-column, in order to develop the versatile
protocol to exploit the dual-tagged expression vector. Franz et al.
showed that the interfering effect of Ni2+ ions to fluorescence of
Tb3+-chelated LBTwhich was adjacently attached to Hisx6 tag,
suggesting that Ni2+ may weakly interact LBT [9]. Indeed, we
found LBT–GST (data not shown) as well as LBT–GST–PTD
(Fig. 2a, lane 2) could bind to Ni2+-column, although its affinity
was not sufficient to purify the proteins from E. coli extract by
itself. Thus, we employed the purification of a dual-taggedFig. 2. Purification of LBT–GST–PTD by different affinity chromatography (a)
and its delivery to HeLa and NIH3T3 cells (b). (a) 15% SDS-PAGE showing the
purification step of LBT–GST–PTD. lane 1, crude extract, lane 2, eluent from
the first heparin Sepharose, lane 3, eluent from Ni2+-chelating Sepharose, lane 4,
eluent from the second heparin Sepharose, lane 5, molecular weight marker, lane
6, LBT–GST–PTD purified by glutathione–Sepharose, lane 7, GST purified by
glutathione–Sepharose (as a control). (b) Western blotting of LBT–GST–PTD
recovered from HeLa and NIH3T3 cells after cellular protein delivery
experiments. Approximately 106 cells were collected after incubation with
different proteins, disrupted, electrophoresed, blotted and detected by anti GST
antibody. lane 1, HeLa with LBT–GST–PTD, lane 2, HeLa with GST, lane 3,
HeLa only, lane 4, NIH3T3 with LBT–GST–PTD, lane 5, NIH3T3 with GST,
lane 6, NIH3T3 only.protein, LBT–GST–PTD, combining the two affinity chroma-
tography methods. The combined use of heparin–Sepharose
followed by a Ni2+-chelating Sepharose column worked
sufficiently well, and the dual-tagged protein has been mostly
purified, as indicated by a single band on SDS-PAGE (Fig.
2a lane 3). We added a further chromatographic step for the
Ni2+–Sepharose column eluent, not only for further purification,
but also to remove the imidazole and Ni2+ ion from the protein
solution. As a result, the purity of LBT–GST–PTD purified by
heparin-Ni2+–heparin affinity columns was adequately high,
when compared to purification of the same protein by a
glutathione–Sepharose column (Fig. 2a lane 4, 6).
3.3. Protein delivery of LBT/PTD dual-tagged GST into HeLa
and NIH3T3 cells
The C-terminally fused HIV-Tat PTD tag in our pGEX–
LBT–GST–PTD vector has been demonstrated to be a potent
enabler of cellular protein delivery. LBT–GST–PTD protein
and GST alone were added to the media of HeLa and NIH3T3
cells. The cells were treated with trypsin and gently washed by
PBS repeatedly, and the protein absorbed to the cell surface was
washed. The Western blot analyses clearly showed that the
cellular uptake of GST occurred only when GSTwas fused with
the HIV-Tat peptide (Figs. 2b, 3a).
When the cells were observed by fluorescent microscopy,
LBT–GST–PTD was found in the perinuclear dot-like
structures, but not in the nucleus, similar to results of delivering
GST–Tat–eGFP [14] (Fig. 3b). The fusion of LBT to the N-
terminus of the cargo proteins apparently does not alter the
protein transduction activity of HIV-Tat. It is similar to the other
reported cases, that the most part of the delivered protein is
captured in endocytotic vesicles, whereas only a few part of the
protein might be delivered into the cell interior. Although we
did not examine the cytosolic activity of the delivered protein,
we eventually observed the LBT–GST–PTD fusion protein
showing ladders of higher molecular weight species that were
reactive to anti-GST antibody (Supplementary Fig. 1a). The
observation may suggest that part of the delivered protein was
post-translationally modified, probably ubiquitination. This
assumption was partially proven, because these higher mole-
cular weight signals decreased when the lysate was treated with
isopeptidase-T (Supplementary Fig. 1b). Thus, a certain part of
the delivered LBT–GST–PTD was likely to be delivered to
cytosolic space where post-translational modification such as
ubiquitination occurs.
3.4. Delivery of Tb3+-chelated LBT/PTD dual-tagged proteins
into HeLa and NIH3T3 cells and its detection by fluorescence
Protein transduction activity of Tb3+-chelated LBT–GST–
PTD and its fluorescent visualization was also examined (Fig.
3c), while DMEM containing 1 μM Tb3+ without the LBT-
fusion protein was used as a control (data not shown). Although
lanthanides are generally toxic, no obvious growth arrest or
toxicity were observed after incubation of HeLa and NIH3T3
cells with either Tb3+ or the Tb3+-chelated LBT–GST–PTD
Fig. 3. Protein transduction of Tb3+-free and Tb3+-chelated LBT–GST–PTD into HeLa (top) and NIH3T3 (bottom) cells. (a, b) Cells were incubated with 1 μMGST
(a) or 1 μMLBT–GST–PTD (Tb3+-free) (b). After methanol fixation, the tagged proteins were visualized by anti-GST antibody with Cy3™-anti mouse IgG antibody,
whereas the nuclei were stained by DAPI, and the two images were overlaid. (c–e) Cells were incubated with a mixture of 1 μMTb3+ and 2 μM LBT–GST–PTD, and
visualized by Tb3+ fluorescence after fixation and DAPI staining (c) or in living cells without fixation (d). Differential interference contrast images of the same region
as D (e).
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fixed, we could clearly observe the delivered Tb3+-chelated
protein in the perinuclear dot-like structures, and this localization
is similar to that visualized by an anti-GST antibody with Cy3™-
anti mouse IgG antibody (Fig. 3c). The Tb3+-chelated protein
was light green after methanol fixation, a color that is consistent
with the emission wavelength of Tb3+ fluorescence (∼540 nm)
and is readily distinguishable from the blue color of the DAPI-
stained nucleus. We also observed the fluorescence of Tb3+-
chelated LBT–GST–PTD in living HeLa and NIH3T3 cells (Fig.
3d), and the localization pattern was essentially the same as
before. After establishing these protocols, we repeated the
experiments by using Tb3+-chelated LBT–UbM–PTD and LBT–
NTRDD–PTD instead of GST-derived proteins (see Supplemen-
tary Fig. 2). Again, fluorescent spots raised from the delivered
LBT-tagged proteins were observed as in the perinuclear dot-like
structures. The results suggested that the localization of the PTD
delivered proteins was not affected by cargo proteins. Alter-
natively, post-delivery staining of Tb3+-free LBT–GST–PTD
with Tb3+ solution after methanol fixation of cells gave no
visually detectable fluorescent spots (data not shown).
4. Discussion
4.1. Technical advantages of the LBT/PTD dual-tagged vector
compared to other existing methods
In this paper, we have demonstrated the LBT/PTD dual-
tagged vector is a versatile tool for cellular protein delivery
experiments. As mentioned by the group who originally
developed LBT, the use of fluorescent Tb3+–LBT has enormous
advantages against other fluorescent reagents because of its
easy incorporation, resistance against fluorescence bleaching,
and the smaller size.
Chemical labeling of proteins with fluorescent reagent, such
as fluorescein, coumarin and rhodamine derivatives, is not
always applicable, because the chemical reaction may occur in a
non specific manner. One of the common strategy for such
purpose is a modification of lysine residues by NHS-derivativesof the fluorescent dyes. Like oligo-arginine type PTD peptides
[5,15], HIV-Tat contains lysines, which are potentially modified
by such fluorescent dyes. In addition, the incorporation of
hydrophobic dyes into proteins and peptides may alter its
affinity to the cellular membrane. It is notable that the
fluorescence of Tb3+ is resistant to natural bleaching in the
cell, in contrast to other chemically conjugated fluorescent dyes.
On the other hand, the small size (2 kDa) of LBT as well as
lack of fixed conformation of Tb3+-free LBT may confer
advantages over GFP-based techniques because of the follow-
ing reasons. First, the larger size (25 kDa) and di- or tetrameric
nature of GFP (and its variants) may decrease efficiency of
protein cellular delivery. Since GFP itself is large enough, a
strategy of making a fusion protein such that GFP-Cargo-PTD
is not ideal. Thus, the monomeric nature of LBT, as judged by
the HSQC spectra of LBT-tagged ubiquitin in vitro [16], makes
this technique advantageous for monitoring the subcellular
localization of the delivered proteins. In addition, heterologous
expression of the protein fused to GFP in E. coli or other
organisms is not always straight forward, because of the protein
folding problem of GFP [17]. Finally, GFP itself does not
provide any purification methods for GFP-fusion proteins,
whereas the LBT/PTD dual tag does.
There are other potential PTDs such as antennapedia
homeodomain, arginine oligopeptides and transportan [reviewed
in 1], that can deliver the heterologous proteins into cells as
well. We chose HIV-Tat as a PTD because specific binding of
HIV-Tat to heparan sulfate has been reported [12].
4.2. Potential application of the LBT/PTD dual-tagged vector
As mentioned previously, we observed LBT/PTD dual-
tagged proteins were delivered into the cells and captured in
endosome-like particles. The fluorescence of Tb3+–LBT
merely diffused in the cytosol, suggesting that very limited
amount of the delivered protein, if present, could reach to
cytosol and/or other cellular spaces, such as nucleus. The
route and the fate of the delivered protein has not yet been
characterized. Nevertheless, some applications seem to
146 N. Goda et al. / Biochimica et Biophysica Acta 1773 (2007) 141–146succeed to deliver the heterologous proteins into nucleus [18].
We hypothesize that the fate and the final destination may
depend on the nature of the cargo protein. Since our LBT/
PTD dual-tagged vector is potent for high-throughput PCR
cloning, our system is applicable for establishing the
mechanism of protein cellular delivery.
In conclusion, our new methodology offers a highly efficient
tool for carrying out protein delivery experiments. We hope it
will find many applications in exploring protein function, from
gene cloning to elucidating cellular function.
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